Phase 1 clinical study for BLU-5937 for the treatment of chronic cough.
Phase of Trial: Phase I
Latest Information Update: 26 Jul 2018
At a glance
- Drugs BLU-5937 (Primary)
- Indications Cough
- Focus Adverse reactions; First in man
- 26 Jul 2018 New trial record
- 09 Jul 2018 According to BELLUS Health media release, dosing has been initiated in healthy subjects .
- 09 Jul 2018 According to BELLUS Health media release, results from this study is expected in the fourth quarter of 2018.